Efficacy of human recombinant erythropoietin plus IFN-α in patients affected by chronic hepatitis C

Journal of Interferon and Cytokine Research

Volumn 24, Issue 10, 2004, Pages 594-599

  Di Fazio, Ignazio ^a   Motta, Massimo ^a   Musumeci, Salvatore ^b,c   Neri, Sergio ^a   Pistone, Giovanni ^a   Malaguarnera, Mariano ^a,d  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c CNR   (Italy)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; FERRITIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASTHENIA; BACKACHE; CHRONIC HEPATITIS; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DRUG EFFICACY; ERYTHROPOIESIS; FEMALE; FEVER; FRIEDMAN TEST; HEADACHE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; TACHYCARDIA; THORAX PAIN; THROMBOCYTOPENIA; VOMITING; WILCOXON SIGNED RANKS TEST;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; DRUG THERAPY, COMBINATION; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRITINS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; IRON; MALE; MIDDLE AGED; TRANSFERRIN;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS;

EID: 4944220411     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/1079990042280892     Document Type: Article

References (24)

1. MALAGUARNERA, M., RESTUCCIA, S., TROVATO, G., SICILIANO, R., MOTTA, M., and TROVATO, B.A. (1995). Interferon alpha treatment in patients with Chronic Hepatitis C. A meta-analytic evaluation. Clin. Drug Invest. 9, 141-149.
2. MALAGUARNERA, M., DI FAZIO, I., FERLITO, L., PISTONE, G., RESTUCCIA, N., TROVATO, B.A., and ROMANO, M. (1998). A comparison of four types of interferon alpha in the treatment of chronic hepatitis C. Curr. Ther. Res. 59, 48-59.
3. FARINATI, F., CARDIN, R., DE MARIA, N., DELLA LIBERA, G., MARAFIN, C., LECIS, E., BURRA, P., FLOREALI, A., CECCHETTO, A., and NACCARATO, R. (1995). Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J. Hepatol. 22, 449-456.
4. FERNANDEZ SALAZAR, L., GARCIA BUEY, L., and MORENO OTERO, R. (1999). Changes in iron metabolism in chronic hepatitis C. Rev. Esp. Enferm. Dig. 91, 583-589.
5. CAGNONI, C., CORSINI, F., PANCOTTI, D., and CARRARA, G. (2000). Effect of iron depletion on long-term response to interferon in patients with chronic hepatitis C with increased plasma iron without accumulation of liver iron. Ann. Ital. Med. Intern. 15, 132-138.
6. TORP-PEDERSEN, S., VYBERG, M., SMITH, E., HOJGAARD, L., HANSEN, U., STADEAGER, C., SCHLICHTING, P., JUUL, N., and GLUUD, C. (1990). Surecut 0.6 mm liver biopsy in the diagnosis of cirrhosis. Liver 10, 217-220.
7. DESMET, V.J., GERBER, M., HOOFNAGLE, J.H., MANNS, M., and SCHEUER, PJ. (1994). Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19, 1513-1520.
8. ISHAK, K., BAPTISTA, A., BRANCHI, I., CALLEA, F., DE GROOTE, J., GUDAT, F., DENK, H., DESMET, V., KORB, G., MACSWEEN, R.N., and PHILLIPS, M.J. (1995). Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696-699.
9. SCHEUER, P.J., DAVIES, S.E., and DHILLON, A.P. (1996). Histopathological aspects of viral hepatitis. J. Viral Hepatitis 3, 277-283.
10. BECKER-ANDRE, M., and HAHLBROCK, K. (1989). Absolute mRNA quantification using the polymerase chain reaction (PCR): a novel approach by a PCR aided transcript titration assay (PAT TY). Nucleic Acids Res. 17, 9437-9446.
11. MALAGUARNERA, M., RESTUCCIA, S., DI FAZIO, I., DI MARCO, R., PISTONE, G., and TROVATO, B.A. (1999). Rapid evolution of chronic viral hepatitis into hepatocellular carcinoma after beta-interferon treatment. Panminerva Med. 41, 51-61.
12. MALAGUARNERA, M., DI FAZIO, I., RESTUCCIA, S., PISTONE, G., RESTUCCIA, N., and TROVATO, B.A. (1998). Efficacy of different schedules in the management of chronic hepatitis C with interferon-α. Ann. Med. 30, 213-217.
13. MALAGUARNERA, M., RESTUCCIA, S., MOTTA, M., RUELLO, P., TROVATO, B.A., and PISTONE, G. (1997). Interferon, cortisone and antivirals in the treatment of chronic viral hepatitis: a review of 30 years of therapy. Pharmacotherapy 17, 998-1005.
14. ARBER, N., KONIKOFF. F.M., MOSHKOWITZ, M., BARATZ, M., HALLAK, A., SANTO, M., HALPERN, Z., WEISS, H., an GILAT, T. (1994). Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases. Dig. Dis. Sci. 39, 2656-2659.
15. 2- microglobulin in patients affected by HCC-HCV correlated. Eur. J. Gastroenterol. Hepatol. 12, 937-939.
16. BONKOVSKY, H.L., BANNER, B.F., and ROTHMAN, A.L. (1997). Iron and chronic viral hepatitis. Hepatology 25, 759-768.
17. BURT, M.J., and COOKSLEY, W.G. (1998). The influence of iron on chronic hepatitis C. J. Gastroenterol. Hepatol. 31, 330-333.
18. MARTIN-VIVALDI, R.. NOGUERAS, F., GONZALEZ, A., QUINTERNO, D., PINEL, L.M., CASTRO, T., and HERNANDEZ. A. (1997). Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism. Rev. Esp. Enferm. Dig. 89, 523-530.
19. BAYRAKTAR. Y., KOSEOGLU, T., SOMNER, C., KAYHAN, B., TEMIZER, A., UZUNALIMOGLU, B., DE MARIA, N., and VAN THIEL, D.H. (1996). The use of deferoxamine infusions to enhance the response rate to interferon-alpha treatment of chronic viral hepatitis B. J. Viral Hepatol. 3, 129-135.
20. IKURA, Y., MORIMOTO, H., JOHMURA, H., FUKUI, M., and SAKURAI, M. (1996). Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am. J. Gastroenterol. 91, 1367-1373.
21. MEANS, R.T., Jr. (1995). Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia. Stem Cells 13, 32-37.
22. CAVILL, I., RICKETTS, C., and NAPIER, J.A. (1977). Erythropoiesis in the anaemia of chronic disease. Scand. J. Haematol. 19, 509-512.
23. PIPERNO, A., SAMPIETRO, M., D'ALBA, R., ROFFI, L., FARGION, S., PARMA, S., NICLI, C., CORBETTA, N., POZZI, M., AROSIO, V., BOARI, G.. and FIORELLI, G. (1996). Iron stores, response to alpha interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver 16, 248-254.
24. SAAB, S., HU, R., IBRAHIM, A.B., GOLDSTEIN, L.I., KUNDER, G., DURAZO, F., HAN, S., VERSIZ, H., GHOBRIAL, R.M., FARMER, D.G., BUSUHIL, R.W., and LASSMAN, C. (2003). Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C. Am. J. Transplant. 3, 328-333.